By Drug Target Review2025-07-23T08:30:29
A new weekly injection developed by University of South Australia scientists could change Parkinson’s treatment by replacing the need for multiple daily pills – potentially helping millions of patients worldwide.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-03-31T14:05:00Z
2026-03-30T09:54:00Z
2023-03-23T14:46:21
Sponsored by Bio-Techne
2024-02-07T14:34:33
Sponsored by BellBrook Labs
2024-02-08T11:07:39
Sponsored by Samplix ApS
2023-11-20T13:43:43
Sponsored by Merck
2024-05-07T13:11:19
Sponsored by BellBrook Labs
Site powered by Webvision Cloud